TheNewsRoom | Johnson & Johnson CEO Sees Leveling In Elective Procedures, May Boost Sales (JNJ)

All of these words:

The exact phrase:

None of these words:

Categories

Date

Providers

Advanced Search

Learn More

Grab Networks has a huge collection of videos from over 300 news sources. Find in-depth news, embed it to your site, and build community!

About Us
Embedding
Getting Paid
Updates

Connect

The Gallery

Bookmark

Johnson & Johnson CEO Sees Leveling In Elective Procedures, May Boost Sales (JNJ)

January 25, 2012

Johnson & Johnson (NYSE:JNJ) CEO William C. Weldon said in an interview that declines in medical spending could be nearing a bottom.The CEO sees signs that a drop in elective procedures including knee and hip replacements is leveling off, and could help boost sales by as much as 2% this year.